Veradermics
Veradermics is a late clinical-stage biopharmaceutical company focused on developing first-in-class treatments for common dermatologic conditions. Their lead candidate, VDPHL01, is an oral therapy for androgenetic alopecia (hair loss). The company also has additional pipeline programs targeting conditions like warts and molluscum contagiosum.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $75M
Date: 11-Dec-2024
Investors: Suvretta Capital Management, Longitude Capital, Surveyor Capital, Osage University Partners, PhiFund, JW Childs Associates, Connecticut Innovations, Vlad Coric, MD
Markets: Biopharmaceuticals, Dermatology, Aesthetics, Pharmaceutical Manufacturing, Therapeutics
HQ: New Haven, Connecticut, United States
Founded: 2019
Website: https://www.veradermics.com
LinkedIn: https://www.linkedin.com/company/veradermics
Twitter: https://twitter.com/veradermics
Facebook: https://www.facebook.com/veradermics
Crunchbase: https://www.crunchbase.com/organization/veradermics
Leave a Comment
Comments
No comments yet.